Overdiagnosis of attention-deficit/hyperactivity disorder in children and adolescents: a systematic scoping review

L Kazda, K Bell, R Thomas, K McGeechan… - JAMA network …, 2021 - jamanetwork.com
Importance Reported increases in attention-deficit/hyperactivity disorder (ADHD) diagnoses
are accompanied by growing debate about the underlying factors. Although overdiagnosis is …

[HTML][HTML] Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan

B Franke, G Michelini, P Asherson… - European …, 2018 - Elsevier
Attention-deficit/hyperactivity disorder (ADHD) is highly heritable and the most common
neurodevelopmental disorder in childhood. In recent decades, it has been appreciated that …

Mental health issues and psychological factors in athletes: detection, management, effect on performance, and prevention: American medical society for sports …

CJ Chang, M Putukian, G Aerni… - Clinical Journal of …, 2020 - journals.lww.com
Abstract The American Medical Society for Sports Medicine convened a panel of experts to
provide an evidence-based, best practices document to assist sports medicine physicians …

[HTML][HTML] The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric …

SV Faraone - Neuroscience & Biobehavioral Reviews, 2018 - Elsevier
Psychostimulants, including amphetamines and methylphenidate, are first-line
pharmacotherapies for individuals with attention-deficit/hyperactivity disorder (ADHD). This …

Childhood and adolescent adversity and cardiometabolic outcomes: a scientific statement from the American Heart Association

SF Suglia, KC Koenen, R Boynton-Jarrett, PS Chan… - Circulation, 2018 - Am Heart Assoc
Adverse experiences in childhood and adolescence, defined as subjectively perceived
threats to the safety or security of the child's bodily integrity, family, or social structures, are …

Attention-deficit/hyperactivity disorder medications and long-term risk of cardiovascular diseases

L Zhang, L Li, P Andell, M Garcia-Argibay… - JAMA …, 2024 - jamanetwork.com
Importance Use of attention-deficit/hyperactivity disorder (ADHD) medications has increased
substantially over the past decades. However, the potential risk of cardiovascular disease …

Drugs that may cause or exacerbate heart failure: a scientific statement from the American Heart Association

RL Page, CL O'Bryant, D Cheng, TJ Dow, B Ky… - Circulation, 2016 - Am Heart Assoc
Heart failure is a common, costly, and debilitating syndrome that is associated with a highly
complex drug regimen, a large number of comorbidities, and a large and often disparate …

Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003–2011

SN Visser, ML Danielson, RH Bitsko… - Journal of the American …, 2014 - Elsevier
Objective Data from the 2003 and 2007 National Survey of Children's Health (NSCH) reflect
the increasing prevalence of parent-reported attention-deficit/hyperactivity disorder (ADHD) …

Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)

OJ Storebø, MRO Storm, JP Ribeiro… - Cochrane Database …, 2023 - cochranelibrary.com
Background Attention deficit hyperactivity disorder (ADHD) is one of the most commonly
diagnosed and treated psychiatric disorders in childhood. Typically, children and …

Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents–assessment of adverse events in non‐randomised studies

OJ Storebø, N Pedersen, E Ramstad… - Cochrane Database …, 2018 - cochranelibrary.com
Background Attention deficit hyperactivity disorder (ADHD) is a common
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …